Patrick Quinn Nova Nordisk Diabetes - Search News

News

Novo Nordisk ousts CEO

Yahoo Finance on MSN · 2d

Novo Nordisk CEO steps down in surprise move as 'market challenges' weigh on obesity drugmaker

CEO Lars Jørgensen is stepping down from his post after eight years in the role, during which he lead the company to an all-time high in the markets. Despite being the first-to-market in the latest generation of GLP-1 drugs,

Fox Business on MSN · 2d

Novo Nordisk CEO steps down as Wegovy maker faces increased competition

As Novo Nordisk's share price drops, CEO Lars Fruergaard Jorgensen steps down. The company aims to maintain its lead in the competitive weight-loss drug market.

Reuters on MSN · 2d

Analysis-Novo Nordisk should look to the US for its next CEO, analysts say

By Patrick Wingrove and Maggie Fick (Reuters) -As Denmark's Novo Nordisk shops for its next CEO to replace Lars Fruergaard Jorgensen, it should look across the Atlantic for a leader deeply entrenched in the United States,

2don MSN

Novo Nordisk announces CEO transition as share price slips

Lars Rebien Sørensen, who chairs the Novo Nordisk Foundation, will join its board as an observer while the company seeks a ...

4d

Novo Nordisk Inks $2.2 Billion Deal With Septerna To Develop Oral Weight Loss And Diabetes Drugs

Novo Nordisk and Septerna enter $2.2 billion deal to develop oral small-molecule therapies targeting obesity, diabetes, and ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results